EXECUTIVE ENGAGEMENTS BY TIER
HIGHLIGHTS & REPORT INDEX
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market to Reach US$1.8 Billion by 2030
The global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$932.4 Million by the end of the analysis period. Growth in the Alcohols segment is estimated at 4.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$341.3 Million While China is Forecast to Grow at 4.7% CAGR
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market in the U.S. is estimated at US$341.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$280.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Key Trends & Drivers Summarized
Why Are Oral Solid Dosage Forms Dominant in Pharmaceutical Delivery?
Oral Solid Dosage Forms (OSDF), such as tablets and capsules, remain the most common and preferred method of drug delivery in the pharmaceutical industry due to their convenience, stability, and cost-effectiveness. OSDFs are favored by both healthcare providers and patients for their ease of administration and ability to deliver precise doses of medication. These forms also offer greater stability than liquid formulations, with longer shelf lives and better storage conditions, making them ideal for global distribution. With continuous advancements in drug formulation, oral solid dosage forms can now deliver complex drug compounds, including controlled-release and targeted drug delivery systems, offering enhanced therapeutic effects.
What Role Do Pharma Excipients Play in the Development of OSDFs?
Pharmaceutical excipients, which are inactive substances formulated alongside the active drug, play a crucial role in the development and performance of oral solid dosage forms. Excipients are essential in ensuring drug stability, improving bioavailability, and facilitating the manufacturing process. New excipients are being developed to address specific formulation challenges, such as improving the solubility of poorly water-soluble drugs or enabling sustained release mechanisms. Moreover, the rise of biologics and complex drug compounds is driving innovation in excipient technologies, as manufacturers seek novel solutions to ensure these advanced therapies can be effectively delivered in solid dosage form.
How Are Regulatory and Industry Trends Shaping the OSDF and Pharma Excipients Market?
The OSDF and pharma excipients market is closely regulated by global health authorities, ensuring that both the active drug and excipients meet stringent safety, efficacy, and quality standards. These regulations are driving manufacturers to invest in high-quality excipients and state-of-the-art manufacturing processes to ensure compliance with good manufacturing practices (GMP). Additionally, the rise of personalized medicine and the growing demand for patient-centric dosage forms are influencing the market, with a focus on developing tailored excipients and formulations that can accommodate specific patient needs, such as pediatric or geriatric populations. Sustainability is also becoming a key consideration, with companies exploring environmentally friendly excipient alternatives.
The Growth in the OSDF and Pharma Excipients Market Is Driven by Several Factors
The growth in the oral solid dosage forms and pharma excipients market is driven by several factors, including the widespread preference for OSDFs due to their convenience, stability, and cost-effectiveness. Technological advancements in drug formulation and excipient development are enabling the creation of more sophisticated and effective drug delivery systems, including controlled-release and targeted therapies. Regulatory demands for high-quality, compliant excipients are also pushing innovation in this sector. Additionally, the rise of complex drug compounds, biologics, and personalized medicine is creating new opportunities for specialized excipients. Moreover, the increasing demand for sustainable and patient-centric dosage forms is further driving the development of novel excipient technologies.
SCOPE OF STUDY
The report analyzes the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market by the following Segments, and Geographic Regions/Countries:
Segments:
Segment (Polymers, Alcohols, Minerals, Gelatin, Other Segments).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Abitec Corporation; Akzo Nobel NV; Archer Daniels Midland Company; Associated British Foods PLC; Avantor Performance Materials LLC; BASF SE; Cabot Corporation; Cargill, Inc.; Celanese Corporation; Croda International PLC; Dow, Inc.; DuPont de Nemours, Inc.; Eastman Chemical Company; Ferro Corporation; FMC Corporation; FMC Corporation; Huntsman Corporation; Ingredion, Inc.; Innophos Holdings, Inc.; J.M. Huber Corporation; Kuraray Co., Ltd.; Medtronic PLC; Merck KGaA; Nitta Gelatin, Inc.; Procter & Gamble Company, The; Royal Dutch Shell PLC; The Lubrizol Corporation
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients – Global Key Competitors Percentage Market Share in 2024 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 46 Players Worldwide in 2024 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Growing Preference for OSDFs Due to Convenience and Compliance |
Advancements in Excipients for Improved Drug Delivery and Stability |
Rising Demand for Sustained and Controlled-Release Formulations |
Increased Focus on Personalized Medicine and Patient-Centric Therapies |
Expanding Use of High-Functionality Excipients for Complex Formulations |
Growth of the Generic Drugs Market Driving Demand for Cost-Effective Excipients |
Innovations in Excipients for Biopharmaceuticals and Targeted Therapies |
Increasing Investment in R&D for Novel Drug Delivery Systems |
Demand for Excipients with Enhanced Solubility for Poorly Water-Soluble Drugs |
4. GLOBAL MARKET PERSPECTIVE |
World Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Alcohols by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Alcohols by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Alcohols by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Gelatin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E) |
USA Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
JAPAN |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E) |
Japan Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
CHINA |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E) |
China Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
China Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
EUROPE |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E) |
Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR |
Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
FRANCE |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E) |
France Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
France Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
GERMANY |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E) |
Germany Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
UNITED KINGDOM |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E) |
UK Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
ASIA-PACIFIC |
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR |
Rest of World Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Polymers, Alcohols, Minerals, Gelatin and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR |
Rest of World 16-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Segment - Percentage Breakdown of Value Sales for Polymers, Alcohols, Minerals, Gelatin and Other Segments for the Years 2014, 2024 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com